Published: February 2011
Pages: 196
This GAMP® Good Practice Guide offers practical guidance for the development, maintenance, and management of GxP-compliant process control systems in the pharmaceutical industry. Using the GAMP® 5 framework, it supports science-based quality risk management across a range of systems—from simple instruments to complex distributed control environments.
This guide applies the core principles of GAMP® 5 and ICH Q9 to help professionals ensure that pharmaceutical GxP process control systems are fit for intended use and meet regulatory expectations. It emphasizes a scalable, risk-based approach and provides actionable insights for implementing effective GxP compliance in pharma manufacturing operations.
This publication is essential for pharmaceutical and biopharmaceutical professionals involved in GxP validation and compliance, including:
For organizations seeking to strengthen GxP compliance for pharma process control systems, this guide delivers both strategic and technical guidance grounded in internationally recognized best practices. It serves as a critical resource for ensuring consistent, compliant, and efficient operations throughout the system lifecycle.
ISPE members located in nations with emerging economies* are eligible for a 50% discount on publications from the regular member price. To receive the discount, members must be logged in with their ISPE member account. Contact Member Services at ask@ispe.org for more information or if you have questions about your membership status or this discount program. Discounts do not apply to Accuris (formerly Techstreet) document downloads.
*Based on the World Bank's system for classifying national economies by GNI per capita. Includes low-income, lower middle-income, and upper middle-income economies. To learn more about the World Bank classification system, please click here. Currently includes the following nations, except where international sanctions apply: